Annals of Surgical Oncology

September 19, 2025.

Citation: Farooq, M.S., Mattfeld, V., Beniwal, P.C. et al. Recurrence Patterns and Survival Outcomes in Clinical Stage IIB/IIC Melanoma: Can We Stratify Patients for Consideration of Neoadjuvant Immunotherapy?. Ann Surg Oncol (2025). https://doi.org/10.1245/s10434-025-18263-z

Synopsis: In this single-institution retrospective cohort study of patients with clinical stage IIB/IIC melanoma, the authors found a 2-year recurrence-free survival of 69%, as well as a significant association of pre-surgical lymphovascular invasion with recurrence.

September 19, 2025.

Citation: Jimenez, R.B., Abdou, Y., Anderson, P. et al. Postmastectomy Radiation Therapy: An ASTRO/ASCO/SSO Clinical Practice Guideline. Ann Surg Oncol (2025). https://doi.org/10.1245/s10434-025-18057-3

Synopsis: The scope of this guideline is to define the role of postmastectomy radiation therapy (PMRT) in the curative-intent management of invasive breast cancer, including the indications for PMRT after upfront surgery and following neoadjuvant systemic therapy, and to discuss the appropriate target volumes and technical specifications for PMRT. This guideline seeks to address the indications and approaches for PMRT in the context of these advances in the multidisciplinary care of breast cancer.